Estimated number of women likely to benefit from bone mineral density measurement in France

被引:10
作者
Amamra, N
Berr, C
Clavel-Chapelon, F
Delcourt, C
Delmas, PD
Derriennic, F
Ducimetière, P
Goldberg, M
Letenneur, L
Rabilloud, M
Meunier, PJ
Schott, AM
机构
[1] Hospices Civils Lyon, Dept Med Informat, F-69003 Lyon, France
[2] GH Pitie Salpetriere, INSERM, U360, F-75651 Paris 13, France
[3] Inst Gustave Roussy, INSERM, Unite XR 521, F-94805 Villejuif, France
[4] INSERM, U500, F-34093 Montpellier 5, France
[5] Hop Edouard Herriot, INSERM, Unite 403, F-69003 Lyon, France
[6] INSERM, U170, F-94807 Villejuif, France
[7] Hop Paul Brousse, INSERM, U258, F-94807 Villejuif, France
[8] Hop Natl St Maurice, INSERM, U88, F-94415 St Maurice, France
[9] Univ Victor Segalen, INSERM, U330, F-33076 Bordeaux, France
[10] Serv Biostat, F-69003 Lyon, France
[11] RTH Laennec, Fac Med, F-69372 Lyon 8, France
关键词
osteoporosis; prevalence; risk factors; absorptiometry; bone mineral density; menopause;
D O I
10.1016/j.jbspin.2003.11.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. - To determine the number of women in France at least 50 years of age with risk factors for osteoporosis likely to lead to bone mineral density measurement, an investigation reimbursed by the French national health insurance system in patients at risk for osteoporosis. The study was commissioned by the French health authorities. Materials and methods. - Risk factors for osteoporosis were defined as recommended by the French Agency for Accreditation and Evaluation in Health (ANAES) in 2001. The study data were from nine cohort studies done in France and from the National Health Insurance Agency for the Rhone-Alpes region of France. Risk factor prevalences in France were standardized by extrapolation according to the age distribution in France. Results. - Overall, data were collected in 123 986 women aged 50 years or older. From these data, risk factor estimates were as follows: menopause before 40 years of age, 1.5 million women; body mass index (BMI) lower than 19 kg/m(2), nearly 700 000; history of fracture, more than 2 million; history of femoral neck fracture in the mother, more than 1 million; history of health problems potentially responsible for osteoporosis, 400 000; and history of long-term glucocorticoid therapy, 612 000. In all, 3186 318 (30%) women were estimated to have at least one risk factor and 785 512 (7.5%) at least two risk factors. Conclusions. - Although our study sample was not representative of the population residing in France, the large sample size and diversity of data sources support the validity of our estimate of the prevalence of risk factors for osteoporosis in postmenopausal women living in France. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:409 / 418
页数:10
相关论文
共 23 条
[11]  
DERRIENNIC F, 1996, AGE TRAVAIL SANTE ET
[12]   Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements:: A systematic review of the literature [J].
Espallargues, M ;
Sampietro-Colom, L ;
Estrada, MD ;
Solà, M ;
del Río, L ;
Setoain, J ;
Granados, A .
OSTEOPOROSIS INTERNATIONAL, 2001, 12 (10) :811-822
[13]   Interim report and recommendations of the World Health Organization task-force for osteoporosis [J].
Genant, HK ;
Cooper, C ;
Poor, G ;
Reid, I ;
Ehrlich, G ;
Kanis, J ;
Nordin, BEC ;
Barrett-Connor, E ;
Black, D ;
Bonjour, JP ;
Dawson-Hughes, B ;
Delmas, PD ;
Dequeker, J ;
Eis, SR ;
Gennari, C ;
Johnell, O ;
Johnston, CC ;
Lau, EMC ;
Liberman, UA ;
Lindsay, R ;
Martin, TJ ;
Masri, B ;
Mautalen, CA ;
Meunier, PJ ;
Miller, PD ;
Mithal, A ;
Morii, H ;
Papapoulos, S ;
Woolf, A ;
Yu, W ;
Khaltaev, N .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (04) :259-264
[14]  
GOURLET V, 2000, ANN GERONTOLOGIQUE, P174
[15]   Guidelines for diagnosis and management of osteoporosis [J].
Kanis, JA ;
Delmas, P ;
Burckhardt, P ;
Cooper, C ;
Torgerson, D .
OSTEOPOROSIS INTERNATIONAL, 1997, 7 (04) :390-406
[16]   Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: A position paper of the European Foundation for Osteoporosis and Bone Disease [J].
Kanis, JA ;
Devogelaer, JP ;
Gennari, C .
OSTEOPOROSIS INTERNATIONAL, 1996, 6 (03) :256-261
[17]  
LASCAUXLEFEBVRE V, 1992, HUM HYPERTENS, V13, P631
[18]  
*NAT OST FDN, 1998, PHYS GUID PREV TREAT
[19]  
*NIH, 2001, JAMA-J AM MED ASSOC, V258, P785
[20]  
*NIH, 2000, NIH CONS DEV C OST P